Home › Liposarcoma › Missouri › St. Louis
Liposarcoma clinical trials in St. Louis, MO
5 studies for Liposarcoma are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
RecruitingPhase 3
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at West County Hospital, Creve Coeur · 12 mi away
- and 1 more
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
RecruitingPhase 3
- Washington University School of Medicine - Siteman Cancer Center, St Louis
- Siteman Cancer Center-South Country, St Louis
- Siteman Cancer Center-West County, Creve Coeur · 12 mi away
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
RecruitingPhase 1
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- Cardinal Glennon Children's Medical Center, St Louis
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
RecruitingPhase 1/2
- Washington University Medical Center, St Louis
Liposarcoma trials in other cities
- Houston, TX10 studies
- Boston, MA7 studies
- Queens, NY5 studies
- New York City, NY5 studies
- Chicago, IL5 studies
- Edison, NJ4 studies
- Atlanta, GA4 studies
- Greenburgh, NY3 studies
- New Rochelle, NY3 studies
- Columbus, OH3 studies
- Seattle, WA3 studies
- Aurora, CO3 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer73 studies
- Breast Cancer64 studies
- Metastatic Cancer54 studies
- Colorectal Cancer50 studies
- Prostate Cancer46 studies
- Cancer (all types)46 studies
- Lung Cancer39 studies
- Ovarian Cancer38 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.